Moreover, MARCH1 could regulate the PI3K‐AKT‐β‐catenin signalling pathway in vitro and vivo, which is a crucial tumour‐related signalling axis in HCC. This evidence concerns the gene MARCHF1 and hepatocellular carcinoma.